Holen Sie sich die Stockscreener-App
6.81
6.17%
-0.4481
Schlusskurs vom Vortag:
$7.2581
Offen:
$6.29
24-Stunden-Volumen:
1,369
Relative Volume:
0.22
Marktkapitalisierung:
$8.48M
Einnahmen:
$186.70K
Nettoeinkommen (Verlust:
$-7.33M
KGV:
-0.8074
EPS:
-8.4345
Netto-Cashflow:
$-2.00M
1W Leistung:
-5.02%
1M Leistung:
-9.68%
6M Leistung:
-36.36%
1J Leistung:
-4.08%
1-Tages-Spanne:
$6.29
$7.15
1-Wochen-Bereich:
$6.29
$7.26
52-Wochen-Spanne:
$6.29
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Firmenname
Addex Therapeutics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare ADXN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
6.88 | 8.94M | 186.70K | -7.33M | -2.00M | -8.4345 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.37 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.22 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.32 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.61 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.49 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Aktie (ADXN) Neueste Nachrichten
Addex Therapeutics (NASDAQ:ADXN) Trading 2% Higher – Here’s Why - Defense World
Addex publishes negative allosteric modulators data in Molecular Psychiatry - TipRanks
CGX Energy (CVE:OYL) Shares Up 17.2% – Should You Buy? - Defense World
FedEx Corporation $FDX Shares Purchased by Transcend Capital Advisors LLC - Defense World
Orex Minerals (CVE:REX) Shares Down 22.8% – What’s Next? - Defense World
Paycom Software (NYSE:PAYC) Price Target Lowered to $210.00 at UBS Group - Defense World
Addex Therapeutics (ADXN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Addex Therapeutics earnings call: Progress amidst financial challenges - MSN
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - TipRanks
Addex Therapeutics Reports Q3 2025 Financial Results - TipRanks
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings - Investing.com India
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Total debt per share of Addex Therapeutics Ltd Sponsored ADR – MUN:APE1 - TradingView
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 5.5% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
How geopolitical risks impact Addex Therapeutics Ltd (APE) stockShare Buyback & Consistent Growth Equity Picks - newser.com
[F-3] Addex Therapeutics Ltd. Foreign Issuer Shelf Registration | ADXN SEC FilingForm F-3 - Stock Titan
Why Addex Therapeutics Ltd (APE) stock stays on buy listsJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Grows By 61.0% - Defense World
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Short Interest Down 91.1% in September - Defense World
Revenue per share of Addex Therapeutics Ltd Sponsored ADR – BER:APE1 - TradingView
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges - MSN
Addex Therapeutics (NASDAQ:ADXN) Shares Up 5.6% – Here’s What Happened - Defense World
Addex Therapeutics’ (ADXN) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Sees Significant Increase in Short Interest - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - TipRanks
Addex Therapeutics H1 2025 Earnings Call Transcript - MarketBeat
Will V.F. Corporation (VFP) stock see valuation expansionExit Point & AI Driven Stock Movement Reports - newser.com
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Lion Group (NASDAQ:LGHL) Stock Price Down 4.3% – Here’s Why - Defense World
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
Can trapped investors hope for a rebound in Vine Hill Capital Investment Corp.Quarterly Profit Report & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Quipt Home Medical Corp.Portfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Is This The Best Time To Buy iSpecimen Inc (NASDAQ: ISPC) Stock? - stocksregister.com
ADR Ratio Change - Yahoo
Addex Therapeutics Ltd Stock Price Today | NASDAQ: ADXN Live - Investing.com
European Equities See Growth In US ADR Market - Finimize
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Addex Stock Soars on Crucial Update From Indivior Research Deal - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2026 - MarketBeat
Earnings call: Addex Therapeutics reports on collaborations and financials - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
What is the current Price Target and Forecast for Addex Therapeutics (ADXN) - Zacks Investment Research
Addex Therapeutics earnings matched, revenue topped estimates - Investing.com India
Where to Find Earnings Call Transcripts - MarketBeat
Most VolatileStock ScreenerNews - Finviz
Finanzdaten der Addex Therapeutics Ltd Adr-Aktie (ADXN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):